BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 31400353)

  • 1. Immunohistochemical expression of mammaglobin in salivary duct carcinomas de novo and salivary duct carcinoma ex pleomorphic adenoma.
    Soares CD; de Lima Morais TM; Carlos R; Martins MD; de Almeida OP; Mariano FV; Altemani A
    Hum Pathol; 2019 Oct; 92():59-66. PubMed ID: 31400353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
    Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
    Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma.
    Griffith CC; Thompson LD; Assaad A; Purgina BM; Lai C; Bauman JE; Weinreb I; Seethala RR; Chiosea SI
    Histopathology; 2014 Dec; 65(6):854-60. PubMed ID: 24804831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.
    Bahrami A; Perez-Ordonez B; Dalton JD; Weinreb I
    Histopathology; 2013 Aug; 63(2):250-62. PubMed ID: 23738717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
    Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE
    Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.
    Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF
    Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases.
    Bahrami A; Dalton JD; Shivakumar B; Krane JF
    Head Neck Pathol; 2012 Sep; 6(3):328-35. PubMed ID: 22485045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of TRKB tyrosine kinase in the two histological types of parotid salivary duct carcinoma with cancer aggressiveness.
    Moriwaki K; Ayani Y; Kuwabara H; Terada T; Higashino M; Kawata R
    Oral Oncol; 2024 Apr; 151():106751. PubMed ID: 38479153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significance of tyrosine kinase receptor B and brain-derived neurotrophic factor expression in salivary duct carcinoma.
    Kondo Y; Hirabayashi K; Carreras J; Tsukinoki K; Ota Y; Okami K; Nakamura N
    Ann Diagn Pathol; 2021 Feb; 50():151673. PubMed ID: 33248386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma ex pleomorphic adenoma of the salivary gland: an immunohistochemical study.
    Matsubayashi S; Yoshihara T
    Eur Arch Otorhinolaryngol; 2007 Jul; 264(7):789-95. PubMed ID: 17310348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling of 149 Salivary Duct Carcinomas, Carcinoma Ex Pleomorphic Adenomas, and Adenocarcinomas, Not Otherwise Specified Reveals Actionable Genomic Alterations.
    Wang K; Russell JS; McDermott JD; Elvin JA; Khaira D; Johnson A; Jennings TA; Ali SM; Murray M; Marshall C; Oldham DS; Washburn D; Wong SJ; Chmielecki J; Yelensky R; Lipson D; Miller VA; Stephens PJ; Serracino HS; Ross JS; Bowles DW
    Clin Cancer Res; 2016 Dec; 22(24):6061-6068. PubMed ID: 27334835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities.
    Katabi N; Xu B; Jungbluth AA; Zhang L; Shao SY; Lane J; Ghossein R; Antonescu CR
    Histopathology; 2018 Jan; 72(2):285-293. PubMed ID: 28796899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.
    Katabi N; Ghossein R; Ho A; Dogan S; Zhang L; Sung YS; Antonescu CR
    Hum Pathol; 2015 Jan; 46(1):26-33. PubMed ID: 25439740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apurinic/apyrimidinic endonuclease 1 (APE1) is overexpressed in malignant transformation of salivary gland pleomorphic adenoma.
    Silva LP; Santana T; Sedassari BT; de Sousa SM; Sobral APV; Freitas RA; Barboza CAG; de Souza LB
    Eur Arch Otorhinolaryngol; 2017 Aug; 274(8):3203-3209. PubMed ID: 28523411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased SOX2 expression in salivary gland carcinoma ex pleomorphic adenoma progression: an association with adverse outcome.
    Sedassari BT; Rodrigues MFSD; Conceição TS; Mariano FV; Alves VAF; Nunes FD; Altemani A; de Sousa SCOM
    Virchows Arch; 2017 Dec; 471(6):775-784. PubMed ID: 28842747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acantholytic Squamous Cell Carcinoma and Salivary Duct Carcinoma Ex-pleomorphic Adenoma of the Submandibular Gland: A Report of Two Extremely Rare Cases with an Immunohistochemical Analysis.
    Kusafuka K; Kawasaki T; Onitsuka T; Hamaguchi N; Morita K; Mukaigawa T; Nishiya Y; Kamijo T; Iida Y; Nakajima T; Sugino T
    Head Neck Pathol; 2020 Mar; 14(1):230-238. PubMed ID: 30484070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
    de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV
    Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary duct carcinoma ex pleomorphic adenoma: analysis of the findings in fine-needle aspiration cytology and histology.
    Ersöz C; Cetik F; Aydin O; Cosar EF; Talas DU
    Diagn Cytopathol; 1998 Sep; 19(3):201-4. PubMed ID: 9740996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
    Hoch BL; Wu M; Lewis M; Gan L; Burstein DE
    J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions.
    Di Palma S
    Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S68-76. PubMed ID: 23821206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.